For UK trade, life-science, regional and national media only: Eisai pledges its support for the Babraham Research Campus’ Accelerate@Babraham initiative; supporting early-stage science and new life science companies within the cluster
For European medical/trade media only: Clinical practice data demonstrates clinical effectiveness and tolerability of Zebinix® (eslicarbazepine acetate) as adjunctive therapy in epilepsy patients with psychiatric comorbidities
For European medical media only: New pan-European report highlights feeling of isolation among people with metastatic breast cancer and need for healthcare professionals to care for emotional demands of disease
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
Click 'cancel' to return to Eisai's site or 'continue' to proceed.